We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$389B
AUM Growth
+$36.3B
Cap. Flow
-$17.4B
Cap. Flow %
-4.48%
Top 10 Hldgs %
19.75%
Holding
5,916
New
643
Increased
1,905
Reduced
2,520
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 14.23%
2 Consumer Discretionary 8.46%
3 Healthcare 7.67%
4 Financials 7.46%
5 Communication Services 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBW icon
5276
Build-A-Bear
BBW
$434M
$61K ﹤0.01%
+14,397
New +$55.4K
KERNW
5277
DELISTED
Akerna Corp Warrant
KERNW
$61K ﹤0.01%
65,300
MLSS icon
5278
Milestone Scientific
MLSS
$41.1M
$60K ﹤0.01%
28,170
+1,595
+6% +$2.81K
OTLK icon
5279
Outlook Therapeutics
OTLK
$189M
$60K ﹤0.01%
2,291
-1,575
-41% -$32.9K
TYME
5280
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$60K ﹤0.01%
48,860
-14,229
-23% -$14.6K
NCNA
5281
NuCana
NCNA
$5.49M
$59K ﹤0.01%
+3
New +$72.1K
BPTH
5282
DELISTED
Bio-Path Holdings Inc
BPTH
$59K ﹤0.01%
+840
New +$63K
APM
5283
DELISTED
Aptorum Group
APM
$58K ﹤0.01%
+2,357
New +$58.1K
EGY icon
5284
Vaalco Energy
EGY
$552M
$58K ﹤0.01%
32,855
+17,801
+118% +$22.9K
IDEX
5285
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$58K ﹤0.01%
+234
New +$43.3K
DTEA
5286
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$58K ﹤0.01%
+24,026
New +$37.7K
CMCM
5287
Cheetah Mobile
CMCM
$95.6M
$57K ﹤0.01%
+6,350
New +$63.1K
PAYS icon
5288
Paysign
PAYS
$693M
$57K ﹤0.01%
12,322
-172
-1% -$899
TELL
5289
DELISTED
Tellurian Inc.
TELL
$56K ﹤0.01%
43,920
-332,460
-88% -$376K
IPOF.WS
5290
DELISTED
Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOF.WS
$56K ﹤0.01%
+17,225
New +$46.5K
SBBP
5291
DELISTED
Strongbridge Biopharma plc.
SBBP
$56K ﹤0.01%
23,023
-9,280
-29% -$22.4K
CBUS icon
5292
Cibus
CBUS
$145M
$55K ﹤0.01%
260
-579
-69% -$117K
GB.WS
5293
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
$55K ﹤0.01%
33,333
BIOR
5294
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$55K ﹤0.01%
+42
New +$61.6K
EVOK
5295
DELISTED
Evoke Pharma
EVOK
$54K ﹤0.01%
+146
New +$75.2K
HIO
5296
Western Asset High Income Opportunity Fund
HIO
$338M
$54K ﹤0.01%
10,983
-30,392
-73% -$151K
ACR
5297
ACRES Commercial Realty
ACR
$104M
$53K ﹤0.01%
4,394
-16,461
-79% -$147K
RDGT
5298
Ridgetech Inc
RDGT
$2.69M
$53K ﹤0.01%
1
-1
-50% -$36.1K
GALT icon
5299
Galectin Therapeutics
GALT
$206M
$52K ﹤0.01%
23,161
+2,507
+12% +$6.58K
STRR
5300
DELISTED
Star Equity Holdings
STRR
$52K ﹤0.01%
+2,889
New +$40.2K

Similar funds

Goldman Sachs's Q4 2020 Portfolio in Review

As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.

  • Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
  • Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
  • Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
  • Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
  • Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
  • Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
  • Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.